Global Animal Dewormer Market Size By Type (External Use, Internal Use), By Application (Livestock, Pets), By Region, And Segment Forecasts, 2023 to 2032

The Global Animal Dewormer Market was valued at USD 2.4 billion in 2023 and is projected to reach USD 4.1 billion by 2031, growing at a CAGR of 6.8% during the forecast period from 2023 to 2031. This growth is driven by increasing global demand for livestock products, heightened awareness of animal health, and rising incidences of parasitic infections in animals. Dewormers are crucial for ensuring the optimal health of animals by eliminating internal parasites, thereby enhancing productivity and reducing mortality. The market is experiencing growth across both livestock and companion animal segments, supported by regulatory push for animal welfare and preventive veterinary care.

Drivers:

1. Rising Demand for Livestock Products:

The growing global population and rising income levels are increasing the demand for meat, dairy, and other animal-derived products. Healthy livestock is essential for consistent and safe food production, driving the need for regular deworming.

2. Increasing Pet Ownership and Companion Animal Health Spending:

The growing adoption of pets, especially in urban areas, and increasing expenditure on pet healthcare are fueling demand for deworming products for cats, dogs, and other companion animals.

3. Government Initiatives on Animal Health:

Many governments and regulatory bodies worldwide are launching campaigns and subsidies aimed at improving livestock health through mass deworming programs, particularly in rural and agricultural communities.

Restraints:

1. Risk of Drug Resistance:

The indiscriminate or repeated use of the same class of dewormers can lead to resistance among parasites, reducing treatment efficacy and presenting a significant challenge to market growth.

2. Regulatory and Approval Delays:

The stringent regulatory processes for new veterinary pharmaceutical products can delay the introduction of novel and effective dewormers into the market.

Opportunity:

1. Growth in Preventive Veterinary Healthcare:

There is a significant opportunity in the increasing shift from reactive to preventive veterinary care, particularly in developed markets, where pet owners and farmers alike are emphasizing routine deworming schedules.

2. Emerging Markets Expansion:

Regions like Asia-Pacific, Latin America, and Africa present vast untapped opportunities due to rising awareness, improved veterinary infrastructure, and increasing animal healthcare spending.

Market by System Type Insights:

Based on product type, oral dewormers held the largest market share in 2023 due to ease of administration and widespread use across both livestock and pets. However, the injectable dewormers segment is expected to witness the highest growth rate during the forecast period, favored for their higher efficacy and longer-lasting effects in large-scale livestock operations.

Market by End-use Insights:

In terms of end use, the livestock segment dominated the market in 2023, accounting for over 60% of the global revenue. This dominance is driven by the increasing demand for meat and dairy products and the need for regular deworming in poultry, cattle, and swine. The companion animal segment is growing steadily, driven by increased spending on pet health and routine veterinary check-ups in urban centers.

Market by Regional Insights:

North America held the largest market share in 2023, supported by robust veterinary healthcare systems, high awareness levels, and strong presence of key industry players. However, Asia-Pacific is anticipated to register the fastest growth during the forecast period, propelled by expanding livestock farming, increasing pet ownership, and growing investments in veterinary services across countries like China, India, and Indonesia.

Competitive Scenario:

Prominent players in the global animal dewormer market include Zoetis Inc., Boehringer Ingelheim, Merck Animal Health, Elanco Animal Health, Virbac, Vetoquinol, Ceva Santé Animale, Bayer AG (Animal Health division), Bimeda Animal Health, and Phibro Animal Health Corporation. These companies are actively involved in strategic acquisitions, product launches, and expansion into emerging markets to solidify their market positions.

Scope of Work – Global Animal Dewormer Market

Key Market Developments:

2023: Zoetis launched a new broad-spectrum oral dewormer targeting common gastrointestinal parasites in both dogs and cats.

2024: Merck Animal Health introduced a long-acting injectable dewormer for cattle, enhancing compliance and reducing labor costs in herd management.

2025: Elanco announced a strategic collaboration with a veterinary chain in Southeast Asia to promote awareness and accessibility of deworming products in emerging markets.

FAQs:

1. What is the current market size of the Global Animal Dewormer Market?

The market was valued at USD 2.4 billion in 2023.

2. What is the major growth driver of the Global Animal Dewormer Market?

Rising demand for livestock-derived food products and increasing focus on animal health are the primary growth drivers.

3. Which is the largest region during the forecast period in the Global Animal Dewormer Market?

North America currently leads the market, though Asia-Pacific is expected to witness the fastest growth.

4. Which segment accounted for the largest market share in Global Animal Dewormer Market?

The livestock segment accounted for the largest market share in 2023.

5. Who are the key market players in the Global Animal Dewormer Market?

Key players include Zoetis Inc., Merck Animal Health, Boehringer Ingelheim, Elanco, and Virbac.